Deal Watch: Sanofi, Boehringer Swap Side Businesses

 
• By Malcolm Spicer, Lisa LaMotta, Eleanor Malone, Mandy Jackson, Sukaina Virji, and Scott Steinke

Busy week for AstraZeneca sees buyout of Acerta and acquisition of remaining Daliresp/Daxas worldwide rights from Takeda. Amgen and GSK undo their cancer drug alliances from 2009 and 2010, with all rights reverting to the big biotech.

More from Archive

More from Pink Sheet